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Stomatin-Like Protein 2 Binds Cardiolipin and Regulates
Mitochondrial Biogenesis and Function
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Stomatin-like protein 2 (SLP-2) is a widely expressed mitochondrial inner membrane protein of unknown
function. Here we show that human SLP-2 interacts with prohibitin-1 and -2 and binds to the mitochondrial
membrane phospholipid cardiolipin. Upregulation of SLP-2 expression increases cardiolipin content and the
formation of metabolically active mitochondrial membranes and induces mitochondrial biogenesis. In human
T lymphocytes, these events correlate with increased complex I and II activities, increased intracellular ATP
stores, and increased resistance to apoptosis through the intrinsic pathway, ultimately enhancing cellular
responses. We propose that the function of SLP-2 is to recruit prohibitins to cardiolipin to form cardiolipin-
enriched microdomains in which electron transport complexes are optimally assembled. Likely through the
prohibitin functional interactome, SLP-2 then regulates mitochondrial biogenesis and function.
The demands for energy-generating substrates in a eukary-
otic cell rise as the cell transitions from a resting state to an
activated state. This process is well documented in lympho-
cytes undergoing mitogenic responses. In these cells, the
increasing energy requirements are met by increased pro-
duction of ATP either by glycolysis or by oxidative phos-
phorylation (OXPHOS); both processes are regulated by
signaling from antigen receptors and costimulatory molecules
(14–16). Scattered evidence suggests that these demands on
cellular bioenergetics correlate with augmentation of the mi-
tochondrial membrane surface and of mitochondrial numbers
(8, 12, 34), a finding consistent with the key role played by
these organelles in supplying most cellular ATP (14). However,
the molecules that regulate mitochondrial biogenesis in re-
sponse to cell activation remain mostly unknown.
Recent evidence suggests that the biogenesis of mitochon-
drial membranes may be regulated by the functional interac-
tome of prohibitin 1 (PHB-1) and PHB-2 (35), but it is not
known how prohibitins sense the need to increase mitochon-
drial membrane biogenesis. We have previously reported that
SLP-2, an evolutionarily conserved mitochondrial protein be-
longing to the stomatin family (19, 37, 43) and enriched in
detergent-insoluble microdomains of T lymphocytes, is up-
regulated during the activation of these cells and enhances T
cell responses in vivo and in vitro (28). The function of SLP-2
is unknown. Since SLP-2 is located mostly in mitochondrial
membranes and has been shown to interact with PHB-1 and
PHB-2 (11), we hypothesized that upregulation of SLP-2 ex-
pression may act as a linker between PHBs and mitochondrial
biogenesis. Here we show that SLP-2 binds cardiolipin (CL)
and facilitates the assembly of respiratory chain components.
Upregulation of SLP-2 expression then translates into en-
hanced mitochondrial biogenesis and function.
MATERIALS AND METHODS
Cells. Jurkat T cells were obtained from the American Type Culture Collec-
tion (Manassas, VA). The LG2 B lymphoblastoid cell line used for antigen-
presenting cells was provided by Eric Long (NIAID, NIH, Rockville, MD).
Peripheral blood mononuclear cells (PBMCs) were isolated from normal donors
using Ficoll-Hypaque (Amersham Pharmacia Biotech, Uppsala, Sweden). Cells
were washed and resuspended at 1  106/ml. PBMC blasts were generated
with phorbol myristate acetate (PMA; 1 ng/ml) and ionomycin (100 ng/ml) at
37°C for 72 h.
Plasmids, small interfering RNA (siRNA), and T cell transfectants. Full-
length human SLP-2 cDNA was subcloned into the pEGFPN1 expression vector
(Clontech Inc., Palo Alto, CA) to create an in-frame translational fusion of
SLP-2 with green fluorescent protein (GFP) at the 3 end (SLP-2-GFP) as
described previously (28). The full-length SLP-2-GFP construct was placed in the
doxycycline-inducible pBig2i vector (5). A doxycycline-inducible mutant of hu-
man SLP-2 lacking the amino-terminal domain tagged with GFP was also con-
structed. Stable transfectants were generated by nucleofection.
Upregulation of SLP-2 expression. For induction of high levels of SLP-2
expression, doxycycline (Sigma, St. Louis, MO) was added in culture at 1 g/ml
for 18 to 24 h. Parental cells, which express low levels of SLP-2, are referred to
as low expressors (SLP-2lo), whereas SLP-2-GFP-transfected T cells cultured in
the presence of doxycycline are referred to as high expressors (SLP-2hi). Trans-
fection of pBig2iGFP, pBig2iSLP2GFP, or pmaxGFP (Amaxa, Gaithersburg,
MD), or mock transfection, into human PBMCs or isolated primary CD4 T
helper cells was conducted using the Human T Cell Nucleofector kit (Amaxa).
After transfection, cells were cultured for 24 h before stimulation.
Antibodies. The following monoclonal antibodies (MAb) were used in these
studies: OPA-1 and DLP1 (Drp1) (BD Biosciences, Mississauga, Ontario, Can-
ada), cytochrome c, complex I subunit NDUFS3, the 70-kDa subunit of complex
II, complex III cor-2 subunit II of complex IV, and the alpha subunit of complex
V (MitoSciences, Eugene, OR), -actin (Santa Cruz Biotechnology, Santa Cruz,
CA), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Chemicon In-
ternational, Temecula, CA). Rabbit polyclonal antibodies against Mfn2 (Sigma,
St. Louis, MO), PGC-1 (Santa Cruz Biotechnology, Santa Cruz, CA), and
SLP-2 (Proteintech Group, Inc., Chicago, IL) were also used.
* Corresponding author. Present address: Duff Medical Building,
Room 511, McGill University, 3775 University St., Montreal, Que-
bac H3A 2B4, Canada. Phone: (514) 398-3914. Fax: (514) 398-7052.
E-mail: joaquin.madrenas@mcgill.ca.
 Published ahead of print on 11 July 2011.
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Reagents. The following working concentrations were used: 4 M oligomycin
and 1 g/ml ionomycin (both from Sigma). [3H]acetate and [1-14C]linoleic acid
were obtained from Amersham (Oakville, Ontario, Canada). Lipid standards
were obtained from Serdary Research Laboratories, Englewood Cliffs, NJ. Thin-
layer chromatographic plates (silica gel G; thickness, 0.25 mm) were obtained
from Fisher Scientific (Winnipeg, Manitoba, Canada). Ecolite scintillant was
obtained from ICN Biochemicals (Montreal, Quebec, Canada). Primers for real
time-PCR were obtained from Invitrogen. All other chemicals were certified
ACS grade or better and were obtained from Sigma Chemical Company or
Fisher Scientific.
Confocal microscopy. Confocal microscopy was performed with a Zeiss LSM
510 microscope (Carl Zeiss, Inc.) (2). Photobleaching experiments to test for
mitochondrial fusion were carried out by targeting an area of MitoTracker Red
CMXRos-labeled mitochondria within a cell for repeated exposure to a high-
power HeNe1 laser. Loss of fluorescence at the targeted point was then com-
pared with the fluorescence at an unrelated point within the same cell or another
cell. A similar loss in fluorescent intensity from the unrelated point within the
same cell indicated mitochondrial fusion between the two points.
Transmission electron microscopy. Cells were fixed in 2.5% glutaraldehyde in
0.1 M sodium cacodylate buffer for 2 h, washed in the buffer, fixed in 1% osmium
tetroxide in 0.1 M sodium cacodylate buffer for 1 h, washed in the buffer again,
and enrobed in Noble agar. Following a wash in distilled water, cells were stained
with 2% uranyl acetate for 2 h, dehydrated through a graded series of ethanol,
cleared in propylene oxide, infiltrated with Epon resin, and embedded. Thin
sections were stained with 2% uranyl acetate and lead citrate and were viewed
with a Philips 410 transmission electron microscope.
Measurement of mitochondrial mass. Human PBMCs were labeled with 100
nM MitoTracker Red CMXRos (Invitrogen) for 20 min at 37°C in complete
RPMI 1640. Fluorescence was detected by flow cytometry and was analyzed with
FlowJo flow cytometry analysis software (Tree Star, Inc., Ashland, OR). To
inhibit cardiolipin synthase during in vitro activation, human PBMCs were stim-
ulated with 1 ng/ml PMA and 100 ng/ml ionomycin in the presence of 4 M
triacsin C at 37°C for 24 h (22).
Measurement of cardiolipin. Human PBMCs, resting or blasted, were labeled
with 10 nM nonyl acridine orange (Sigma) for 15 min at 37°C. Fluorescence was
detected by flow cytometry.
Measurement of cardiolipin mass in stable SLP-2-GFP-transfected Jurkat
cells. Jurkat cells stably transfected with doxycycline-inducible SLP-2-GFP were
incubated without (SLP-2lo) or with (SLP-2hi) 1 g/ml doxycycline for 72 h. After
incubation, the medium was aspirated, and the dishes were washed twice with 2
ml of ice-cold phosphate-buffered saline. Cells were harvested in 2 ml of meth-
anol-water (1:1, by volume), and 25-l aliquots were taken for protein determi-
nation (31). Subsequently, 0.5 ml of water and 2 ml chloroform were added to
initiate phase separation. Samples were centrifuged at 2,000 rpm for 10 min, and
the upper phase was aspirated. Two milliliters of the theoretical upper phase
(methanol–0.9% NaCl–chloroform) (48:47:3, by volume) was added, and cen-
trifugation was repeated for 5 min. The organic phase was removed, dried under
nitrogen gas, and resuspended in chloroform-methanol (2:1, by volume). A 50-l
aliquot was spotted onto thin-layer plates for the separation of cardiolipin from
other phospholipids as described elsewhere (35). Phospholipids were removed
from the plate, and the phospholipid phosphorus content of cardiolipin was
determined as described previously (39).
Radiotracer studies of de novo cardiolipin synthesis. SLP-2lo or SLP-2hi cells
were grown in Dulbecco’s modified Eagle medium (DMEM) with 10% fetal
bovine serum (FBS), 100 U penicillin, and 100 g streptomycin in 60-mm-
diameter dishes and were incubated at 37°C under a humidified atmosphere of
5% CO2. Cells were then incubated immediately after doxycycline treatment
with 0.1 M [3H]acetate (10 Ci/dish) for 16 h or with 0.1 mM [1-14C]linoleic
acid (3 Ci/dish) bound to albumin (molar ratio, 1:1) for 8 h. Cells were har-
vested, and the amount of radioactivity incorporated into cardiolipin was deter-
mined as described previously (21).
Real time-PCR. The cycler protocol for real-time PCR consisted of a 30-min
reverse transcription (RT) step at 50°C, followed by a 15-min Taq activation step
at 95°C, followed by a 1-min separation at 95°C and a melting curve that
increased in temperature incrementally from 60°C to 95°C over the course of 20
min. The primers used for real time-PCR were Invitrogen’s D-LUX 6-carboxy-
fluorescein (FAM)-labeled primer sets: for cardiolipin synthase, reverse primer
CGAACCGTGGTGTTGGAAGAGTT-FAM-G and forward primer CGAGA
GATGTAATGTTGATTGCTG; for phosphatidylglycerol phosphate synthase,
reverse primer CGGTGAGTCACTCAGGTTTGCACC-FAM-G and forward
primer TCGGCCTCCAGCACATTAAG; for PGC-1, reverse primer TGC
TTC GTC GTC AAA AAC AG and forward primer TCA GTC CTC ACT GGT
GGA CA; and for 18S rRNA, reverse primer CGGGTGCTCTTAGCTGAG
TGTCC-FAM-G and forward primer CTCGGGCCTGCTTTGAACAC.
Changes in mRNAs were analyzed on an Eppendorf Mastercycler ep Realplex
system with software version 1.5.474, and data are presented as the mean fold
change (2CT) in mRNA expression relative to 18S rRNA expression (30).
Mitochondrial DNA quantification. Mitochondrial cytochrome c oxidase I
(CCO) and the nuclear polymerase 	 accessory subunit were amplified from total
cellular DNA (10). Relative levels of mitochondrial DNA were determined by
comparing the threshold cycle (CT) detection values of CCO in SLP-2hi and
SLP-2lo cells and were normalized to nuclear DNA levels by the CT method
(30).
Cell lysate preparation. Cells were lysed in a 1% Triton X-100-containing
buffer (1% Triton X-100, 150 mM NaCl, 10 mM Tris [pH 7.6], 5 mM EDTA, 1
mM sodium orthovanadate, 10 g/ml leupeptin, 10 g/ml aprotinin, 25 M
p-nitrophenyl-p-guanidinobenzoate) at 4°C for 30 min. Lysates were cleared by
centrifugation (10,700  g, 4°C, 10 min), mixed with sample buffer containing
-mercaptoethanol, boiled, and blotted (7).
Mitochondrion isolation. Intact mitochondria were isolated from 5  106 to
10  106 Jurkat T cells using the Qproteome Mitochondria Isolation kit
(Qiagen). Mitochondrial preparations were mixed with sample buffer con-
taining -mercaptoethanol, boiled, and analyzed by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE).
Prohibitin and SLP-2 membrane association. Mitochondria were isolated and
fractionated with 0.1 M Na2CO3 as described previously (20). Fractions treated
with H2O were used as an input control. Soluble and membrane fractions were
analyzed by immunoblotting for PHB-1 and SLP-2.
NADH dehydrogenase activity. NADH dehydrogenase activity from whole-cell
lysates was measured using the complex I enzyme activity microplate assay kit
(MitoSciences).
ATP quantitation. Mitochondrial and total-cell-lysate ATP levels were mea-
sured using the ATP determination kit (Molecular Probes, Eugene, OR). Briefly,
10 l of ATP standards (ranging from 1.95 to 1,000 nM), mitochondrial fractions,
or cell lysates were added in triplicate to 90 l of a standard reaction solution in
a 96-well Chromalux luminescent assay microplate (Dynex Technologies, Chan-
tilly, VA). Sample luminescence was measured using an MLX microtiter plate
luminometer (Dynex Technologies). Sample ATP concentrations were calcu-
lated from the standard curve and were normalized to cell equivalents.
T cell stimulation. Jurkat T cells were stimulated as described previously (2).
A CD4 T cell isolation kit and MACS (magnetic cell sorting) columns (Miltenyi
Biotec, Inc., Auburn, CA) were used to isolate primary CD4 T helper cells from
PBMCs. pBig2iGFP-, pBig2iSLP2GFP-, pmaxGFP-, or mock-transfected
PBMCs (0.2  106 cells/group) in the presence or absence of 1 g/ml doxycycline
were plated in triplicate on 96-well plates with various concentrations of staph-
ylococcal enterotoxin E (SEE) at 37°C under 5% CO2 for 24 h. Supernatants
were collected, and interleukin-2 (IL-2) was measured by an enzyme-linked
immunosorbent assay (ELISA) (9).
Oxygen consumption. Cells were incubated in a 96-well oxygen biosensor
system (Becton Dickinson [BD], San Jose, CA). Background fluorescence was
measured before plating of cells, and specific fluorescence due to oxygen con-
sumption was measured after 24 h of incubation at 37°C. The fluorescent signal
was measured on a Safire fluorescent plate reader (Tecan, Switzerland). To
calculate [O2] from fluorescence intensity, we followed the protocol supplied by
BD: [O2] 
 [(DR/NRF)  1]/KSV, where NRF is normalized relative fluores-
cence, calculated as the fluorescence intensity of cells (I) divided by the fluores-
cence intensity of a blank well (IB); DR is calculated as the fluorescence intensity of
100 mM sodium sulfite (IS) divided by IB; and KSV is calculated as (DR 1)/[O2]A,
where [O2]A equals 195 M at 37°C with 5% CO2.
Induction and detection of apoptosis. T cells were treated with 5 g/ml of
actinomycin D (Sigma) for 3 h to induce apoptosis, which was measured by
flow cytometry as mitochondrial transmembrane potential (m) loss using
the cell-permeant probe MitoTracker Red CMXRos (Invitrogen), or as an
increase in annexin V staining.
Generation of hrSLP-2. We generated a human recombinant SLP-2 (hrSLP-2)
cDNA coding for amino acids 36 to 356 of human SLP-2 downstream of a
sequence coding for a 6His tag, a thrombin cleavage site, thioredoxin, and a
tobacco etch virus (TEV) cleavage site in a pET-28 plasmid. Rosetta strain
Escherichia coli containing plasmids was streaked, and single colonies were
picked and grown to a A600 of 0.5 to 0.6. The culture was cooled to 15°C and was
induced with 0.1 mM isopropyl--D-thiogalactopyranoside (IPTG) overnight.
Bacteria were pelleted, scraped into preweighed 50-ml centrifuge tubes, resus-
pended in 25-ml 50/10 buffer (50 mM Tris [pH 8.0], 10 mM MgCl2), and
centrifuged at 10,000 rpm for 10 min. The supernatant was decanted, and the
pellet was weighed and resuspended in 10 (wet weight) 50/10 buffer. The buffer
was fortified with 1 mM phenylmethylsulfonyl fluoride (PMSF; Sigma), 5 mM
3846 CHRISTIE ET AL. MOL. CELL. BIOL.
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p-aminobenzamidine (Sigma), and Complete protease inhibitor cocktail
(Roche). The bacteria were lysed by two passes at 10,000 lb/in2 in a French
pressure cell, and the lysates were centrifuged for 10 min at 10,000 rpm at 4°C.
The supernatant was decanted into 60-ml ultracentrifuge tubes, spun at 38,000
rpm at 4°C for 90 min, decanted again, and stored at 80°C.
Chromatography was run using Chelating Sepharose Fast Flow resin (GE
BioScience). Two column volumes of NiSO4 were applied to the column in order
to bind the nickel. The column was equilibrated with 10 column volumes of
buffer A (20 mM Tris-HCl [pH 8.0], 100 mM NaCl, 5 mM 2-mercaptoethanol,
10% glycerol, 20 mM imidazole). The sample was added to the column and was
allowed to flow through the resin at a rate of approximately 0.5 ml/min. The
column was washed with 10 column volumes of buffer A, followed by 2 column
volumes of buffer B (20 mM Tris-HCl [pH 8.0], 1 M NaCl, 5 mM 2-mercapto-
ethanol, 10% glycerol) and a further 2 volumes of buffer A. Bound proteins were
eluted by competitive binding with buffer C (20 mM Tris-HCl [pH 8.0], 100 mM
NaCl, 5 mM 2-mercaptoethanol, 10% glycerol, 0 to 500 mM imidazole) and were
collected in 1.5-ml or 5-ml fractions. Fractions were stained with Coomassie
brilliant blue and were analyzed by SDS-PAGE.
Protein samples were dialyzed into 10 mM Tris (pH 8.0) overnight at 4°C. The
protein solution was then brought up to 2 mM EDTA and 1 mM dithiothreitol
(DTT) and was quantitated by the bicinchoninic acid (BCA) method (BCA
protein assay kit; Pierce). The SLP-2 construct was then incubated with TEV
protease (ratio, 1:10) at room temperature for 2 h. After cleavage, the sample
was dialyzed into 10 mM Tris (pH 8.0) overnight at 4°C to remove EDTA
and DTT.
Phospholipid vesicle coprecipitation assay. The phospholipid vesicle copre-
cipitation assay was performed as described previously (4). The required
amounts of phospholipids were transferred to glass vials and were dried under a
gentle stream of nitrogen gas. The required amount of binding buffer (20 mM
Tris [pH 7.5], 150 mM NaCl, 1 mM EDTA) was added, and samples were
incubated for 3 h at 52°C. After this incubation, hrSLP-2 protein was added to
the lipid vesicle solution at a 5:1 ratio of lipid to protein and was incubated for
30 min at 37°C. Samples were centrifuged at 40,000 rpm for 10 min at room
temperature; the supernatant was removed; and pellets were resuspended in
binding buffer. Laemmli sample buffer was added to the supernatant and
pellet fractions, boiled for 7 min, and run on an SDS-PAGE gel. Bovine heart
cardiolipin was purchased from Sigma; chicken egg L--phosphatidylcholine
(PC), L--phosphatidylethanolamine (PE), and L--phosphatidylglycerol,
porcine brain L--phosphatidylserine, and soy L--phosphatidylinositol were
purchased from Avanti Polar Lipids, Inc. (Alabaster, AL).
RESULTS
SLP-2 is localized mostly in mitochondria. Studies by dif-
ferent groups, including our own, have shown that SLP-2 in
human cells is expressed in two pools (11, 20, 28). The major
pool of SLP-2 is associated with the mitochondrial inner
membrane, whereas a quantitatively minor pool is associ-
ated with the plasma membrane. This compartmentalization
was corroborated biochemically by subcellular fractionation
of human T cells (Fig. 1a). SLP-2 was detected in the mem-
brane and organelle/cytoskeleton fractions but not in the nu-
clear or cytosolic compartment. Porin (voltage-dependent an-
ion channel [VDAC]), a protein detected in mitochondrial and
plasma membranes, showed a partitioning pattern similar to
that of SLP-2.
To study the role of SLP-2, we developed stable transfected
cells in which SLP-2 expression can be tightly regulated using
a doxycycline-inducible promoter coding for a C-terminally
GFP tagged SLP-2 protein (SLP-2-GFP). This system allowed
us to control the levels of SLP-2 in human cells (T cells for
these experiments) from very low (basal levels of expression by
Jurkat T cells stably transfected with this cDNA in the absence
of doxycycline; referred to below as SLP-2lo) to high (10- to
100-times-higher expression upon addition of doxycycline; re-
ferred to below as SLP-2hi). With these cells, we corroborated
the predominant localization of SLP-2 in mitochondria both by
biochemical fractionation (Fig. 1b) and by confocal micros-
copy, in which SLP-2-GFP colocalized with the mitochondrial
dye MitoTracker Red (Fig. 1c and d). Such an intracellular
distribution was determined by an N-terminal mitochondrial
targeting sequence (11, 20), as evidenced by the fact that SLP-
2-GFP deletion mutants lacking the N terminus abrogated
mitochondrial localization, whereas expression of the SLP-2
N-terminal domain fused to GFP was sufficient to determine
mitochondrial localization of this protein (data not shown)
(11).
Upregulation of SLP-2 expression increases mitochondrial
biogenesis. To learn about the function of SLP-2, given its
mitochondrial localization, we first examined the effect of in-
duction of SLP-2 expression on mitochondrial mass by using
the system mentioned above. We found that upregulation of
SLP-2 expression, but not of a control protein, induced a sig-
nificant increase in the mass of metabolically active mitochon-
dria (P  0.01), as determined with the intact mitochondrial
label MitoTracker Red (Fig. 2a and b), and a significant in-
crease in the number of mitochondria per T cell (P  0.001)
(Fig. 2c and d). Such mitochondrial biogenesis required ap-
propriate targeting of SLP-2 to mitochondria, as evidenced by
the fact that overexpression of a SLP-2-GFP mutant lacking
the N-terminal mitochondrial targeting sequence (NSLP-2)
did not induce a significant increase in the number of mito-
chondria (Fig. 2c and d), although a slight increase over the
baseline was observed, likely due to limited transport of the
mutant as a dimer with endogenous full-length SLP-2. Further-
more, the increased mitochondrial mass observed after up-
regulation of SLP-2 expression was corroborated by flow cy-
tometry for primary human leukocytes from peripheral blood
in the transition from the resting state (in which they express
low levels of SLP-2) to the primed blasted state (in which they
express high levels of SLP-2) (Fig. 2e and f).
Mitochondrial biogenesis requires de novo synthesis of
cardiolipin, a phospholipid in the mitochondrial membrane.
Since upregulation of SLP-2 expression was associated with
increased mitochondrial biogenesis, we next tested whether
SLP-2 overexpression increased cardiolipin synthesis. A 37%
increase in cardiolipin content (as a percentage of the total
phospholipid phosphorus mass) was detected in SLP-2hi cells
(Fig. 3a). This finding was corroborated in human PBMCs
transitioning from the resting state (i.e., expressing low levels
of SLP-2) to the activated state (i.e., expressing high levels of
SLP-2) by flow cytometry with the cardiolipin dye nonyl
acridine orange (Fig. 3b). Since the loading and retention of this
dye are sensitive to changes in mitochondrial potential (25), we
verified that the increase in cardiolipin content was due to de
novo synthesis of this phospholipid by using radiolabeling as-
says incubating SLP-2lo and SLP-2hi cells with [3H]acetate and
[14C]linoleic acid, both of which are incorporated into newly
synthesized cardiolipin. SLP-2hi cells showed higher levels of
radiolabeled cardiolipin under both incubation conditions than
did SLP-2lo cells (P  0.05) (Fig. 3c and d). Finally, we used
real time RT-PCR to look at the levels of phosphatidylglycerol
phosphate synthase mRNA and cardiolipin synthase mRNA,
since these resulting enzymes are involved in the final steps of
cardiolipin biosynthesis. As expected, the SLP-2hi cells had
consistently higher transcript levels of both enzymes (Fig. 3e
and f), consistent with a state of activation of lipid biosynthesis
VOL. 31, 2011 SLP-2 AND MITOCHONDRIAL BIOGENESIS 3847
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at the transcriptional level. Together, these data led us to
conclude that SLP-2 regulates cardiolipin synthesis, which is
required for the formation of mitochondrial membranes. To
examine the requirement of cardiolipin synthase upregulation
for mitochondrial biogenesis in SLP-2hi cells, PBMCs were
activated with 1 ng/ml PMA and 100 ng/ml ionomycin in the
presence of 4 M triacsin C, an inhibitor of cardiolipin syn-
thase. Under these conditions, the increase in mitochondrial
mass upon T cell activation was blocked (Fig. 3g), indicating a
requirement for cardiolipin synthesis in mitochondrial biogen-
esis induced by SLP-2 upregulation.
In addition to membrane formation, mitochondrial biogen-
esis also requires activation of a nuclear transcription program
that encodes the majority of mitochondrial proteins. This nu-
clear transcriptional program is dependent on PGC-1, a tran-
scriptional coactivator and master regulator of mitochondrial
biogenesis (40). Thus, we performed real-time RT-PCR to
measure the levels of PGC-1 mRNA and found that these
were increased in SLP-2hi cells (Fig. 3h), supporting the idea
that upregulation of SLP-2 expression is associated with an
increase in the expression of mitochondrially targeted genes.
Of interest, induction of SLP-2 expression also resulted in
significant increases in the levels of OPA-1 and mitofusin-2
(P  0.05), both integral mitochondrial membrane proteins
associated with mitochondrial fusion, but not in the levels of
Drp1 (involved in mitochondrial fission), GAPDH, or cyto-
chrome c (data not shown). However, the increases in OPA-1
and mitofusin-2 levels did not translate functionally into en-
hanced mitochondrial fusion.
Mitochondrial biogenesis requires replication of mitochon-
drial DNA. As expected from the data presented above, we
found that upregulation of SLP-2 correlated with a 70% in-
crease in the level of mitochondrial DNA (Fig. 3i). Taken
together, these findings lead us to conclude that higher levels
of SLP-2 stimulate cardiolipin synthesis and mitochondrial bio-
genesis.
FIG. 1. The major pool of SLP-2 in human T cells is located in mitochondria. (a) Subcellular fractions of Jurkat T cells were isolated by
differential centrifugation and were immunoblotted for SLP-2. Serial blotting for GAPDH, histone H1, CD45, and talin was performed to control
for the quality of the fractions. Blotting of porin (VDAC), another protein with a major subcellular pool in the mitochondrial fraction and a smaller
pool in the plasma membrane, is also shown. (b) Mitochondrial and cytosolic fractions of stable T cell SLP-2-GFP transfectants expressing low
(SLP-2lo) and high (SLP-2hi) levels of SLP-2-GFP were isolated by differential centrifugation and were immunoblotted for SLP-2, electron
transport complex III, and -actin. Note that in addition to the endogenous SLP-2 and SLP-2-GFP forms, we detected bands likely reflecting
intermediate SLP-2 degradation fragments. (c) Stably expressed SLP-2-GFP colocalizes with MitoTracker Red CMXRos by confocal microscopy.
Bars, 5 m. (d) Three-dimensional reconstitution image analysis. A lateral view of a T cell attached to a glass slide is shown. The yellow units
represent mitochondria and the mitochondrial network. Images are representative of more than 100 cells from more than 5 independent
experiments.
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FIG. 2. Induction of SLP-2 expression triggers mitochondrial biogenesis in human T cells. (a and b) T cells expressing high levels of SLP-2
(SLP-2hi) and GFP-expressing control cells, which contain lower levels of SLP-2 (SLP-2lo), were stained with MitoTracker Red, and the signal was
quantified in each cell. Bars, 5 m. (c) Mitochondria visualized by transmission electron microscopy were counted for 30 cell slices of SLP-2hi T
cells, SLP-2lo T cells, or T cells expressing a SLP-2 mutant in which the N-terminal mitochondrial targeting sequence was deleted (NSLP-2).
Asterisks indicate significant differences (***, P  0.001; **, P  0.01) as determined by Student’s t test. (d) Representative transmission electron
microscopy images of SLP-2lo, SLP-2hi, and NSLP-2 T cells. Mitochondria are indicated by asterisks. Bars, 2 m. (e) Mitochondrial mass was
measured by flow cytometry in resting (gray) and activated (black) human peripheral blood mononuclear cells after labeling with MitoTracker Red.
The result for the unstained control is shown by a dotted line. (f) Immunoblotting of PBMC whole-cell lysates for SLP-2 demonstrated that SLP-2
levels were upregulated after blasting. -Actin blotting was used as a loading control. Densitometric units of SLP-2 for each group normalized for
actin levels are shown.
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To determine the kinetics of mitochondrial biogenesis in
response to SLP-2 upregulation, MitoTracker Red was used to
measure mitochondrial mass in PBMCs stimulated with PMA
and ionomycin for 48 h. During the first 18 h of stimulation, the
cells had a slight decrease in mitochondrial mass, which was
recovered by 24 h, and mitochondrial mass was elevated by
48 h of stimulation (Fig. 4a). During this time, SLP-2 and
PHB-1 were both found to be upregulated as early as 1 h after
stimulation, while PGC-1 was elevated by 18 h poststimula-
tion (Fig. 4b). This preceded the increase in mitochondrial
biogenesis detected by MitoTracker Red at 24 h poststimula-
tion, implying that SLP-2 upregulation in response to T cell
activation precedes PGC-1 upregulation and the subsequent
increase in mitochondrial biogenesis.
SLP-2 interacts with prohibitins and binds cardiolipin-
enriched microdomains. Next, we examined how upregula-
tion of SLP-2 expression may induce mitochondrial biogen-
esis. Emerging data suggest that mitochondrial biogenesis is
coordinated by a mechanism involving PHB-1 and -2 (17, 35).
These proteins localize within phospholipid-enriched, detergent-
insoluble microdomains in mitochondrial membranes, and their
functional interactome includes genes such as Ups1 and Gep1,
which are linked to the synthesis of the mitochondrial membrane
phospholipids cardiolipin and phosphatidylethanolamine, respec-
tively (17, 35). We noticed that Saccharomyces cerevisiae PHB-2
has a putative transmembrane domain (as predicted by the
transmembrane hidden mark or model [TMHMM] algorithm
[29]), but neither mouse nor human PHBs have such a domain.
FIG. 3. Induction of SLP-2 expression increases de novo cardiolipin biosynthesis, nuclear transcription programs, and mitochondrial DNA
replication. (a) Upregulation of SLP-2 expression in Jurkat T cells induces cardiolipin synthesis. Upregulation of SLP-2 expression in T cells
(SLP-2hi) was induced with doxycycline and was compared with baseline expression of SLP-2 (SLP-2lo). The pool size of cardiolipin was determined
and was expressed as a percentage of the total phospholipid phosphorus mass. (b) Cardiolipin levels in naïve (gray) and in vitro-activated (black)
PBMCs were measured by flow cytometry after staining with nonyl acridine orange. The result for the unstained control is shown by a dotted line.
(c and d) Incorporation of [3H]acetate (c) and [14C]linoleic acid (d) into cardiolipin in SLP-2lo and SLP-2hi T cells. Data are shown as dpm/mg
of total cellular protein. (e and f) Real-time PCR analysis of the transcript levels of phosphatidylglycerol phosphate synthase (e) and cardiolipin
synthase (f) in SLP-2lo and SLP-2hi T cells. (g) The mitochondrial mass in naïve (shaded histogram) and in vitro-activated PBMC in the absence
(thin line) or presence (thick line) of triacsin C was measured by flow cytometry after staining with MitoTracker Red. The result for the unstained
control is shown by a dotted line. (h and i) Real-time PCR analysis of the transcript levels of PGC-1 (h) and of the mitochondrial DNA content
(i) in SLP-2lo and SLP-2hi T cells. The results shown here are representative of at least 3 independent experiments. *, P  0.05.
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Of interest, S. cerevisiae does not have a homolog of SLP-2, the
closest being PHB-1, with a Clustal W score of 15 (41). This
suggested that, in mammals, SLP-2 may act to link PHBs and
phospholipid-enriched detergent-insoluble microdomains in
mitochondrial membranes. Such a possibility is consistent with
the observations that PHBs are upregulated in parallel with
SLP-2 during activation (38) (Fig. 4b) and that SLP-2 interacts
with PHBs (11).
We first confirmed that human SLP-2 interacted with PHB-1
and PHB-2 in T cells by using standard coprecipitation exper-
iments (Fig. 5a). We found that immunoprecipitates of SLP-2
contained both PHB-1 and PHB-2, as previously reported (11).
Furthermore, coprecipitation of PHB-1, PHB-2, and SLP-2
increased as the expression of SLP-2 increased with increasing
levels of doxycycline in the culture (Fig. 5b). To demonstrate
that SLP-2 plays a role in linking prohibitins to phospholipid-
enriched detergent-insoluble microdomains, we isolated mi-
tochondria from SLP-2lo and SLP-2hi cells and extracted
mitochondrial membranes with Na2CO3. We found a higher
association of PHB-1 with the mitochondrial membrane frac-
tion in SLP-2hi cells, although the total levels of PHB-1 were
similar in the SLP-2lo and SLP-2hi cells (Fig. 5c).
Next, we generated human recombinant SLP-2 (hrSLP-2)
and examined the profile of interaction of this protein with
different phospholipids by using a phospholipid vesicle co-
precipitation assay (4). In this assay, molecules that interact
with phospholipids cosediment with the vesicles, whereas non-
interacting proteins remain in the supernatant. We found that
hrSLP-2 coprecipitated with cardiolipin vesicles (Fig. 6a, P
[pellet fraction]), whereas most of the hrSLP-2 remained in
solution when vesicles made of other phospholipids found in
mitochondria (phosphatidylcholine and phosphatidylethanol-
amine) or vesicles made of mostly nonmitochondrial phospho-
lipids (phosphatidylinositol and phosphatidylserine) were used
(Fig. 6a, S [supernatant fraction]). Of interest, hrSLP-2 bound
to phosphatidylglycerol vesicles in smaller amounts, a finding
likely due to the fact that cardiolipin is a composite of two
phosphatidylglycerol molecules. To further investigate the as-
sociation of hrSLP-2 with cardiolipin, we prepared phospho-
lipid vesicles containing cardiolipin along with the other two
major phospholipids in mitochondria, phosphatidylcholine and
phosphatidylethanolamine, at ratios of 1:1:1 (33% CL, 33%
PC, 33% PE), 2.5:0.25:0.25 (83% CL, 8% PC, 8% PE), and
2.75:0.12:0.12 (92% CL, 4% PC, 4% PE). The interaction
between hrSLP-2 and cardiolipin was selective and titrated
with the enrichment of this phospholipid in vesicles also contain-
ing phosphatidylcholine and phosphatidylethanolamine (Fig. 6b).
These data demonstrate that SLP-2 binds to the prohibitin
complex as well as to cardiolipin-enriched membrane microdo-
FIG. 4. SLP-2 upregulation precedes PGC-1 upregulation and mitochondrial biogenesis during T cell activation. (a) PBMCs were stimulated
with 1 ng/ml PMA and 100 ng/ml ionomycin for as long as 48 h. At the indicated time points, cells were stained with MitoTracker Red and were
analyzed for mitochondrial mass by flow cytometry. Gray, unstimulated cells; black, stimulated cells. (b) Whole-cell lysates were made at each
indicated time point during stimulation with PMA and ionomycin. The lysates were separated by SDS-PAGE and were serially blotted for PGC-1,
PHB-1, SLP-2, and actin.
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mains, potentially mediating the association between prohib-
itins and mitochondrial membranes.
Upregulation of SLP-2 expression is associated with in-
creased mitochondrial functions. To examine the functional
effects of upregulation of SLP-2 expression, we first deter-
mined the activity of citrate synthase, an enzyme of the citric
acid cycle, which is localized to the mitochondrial matrix. We
found that SLP-2hi cells showed significantly increased citrate
synthase activity (P  0.01) (Fig. 7a). Next, we measured the
activity of the electron transport complexes in the respiratory
chain. We found that SLP-2hi cells had significantly higher
activities of NADH dehydrogenase and succinate dehydroge-
nase (P  0.05), complexes I and II of the electron transport
chain (Fig. 7b and c). In addition, mitochondrial and whole-cell
ATP levels in resting SLP-2hi T cells were significantly higher
than those in SLP-2lo T cells (P  0.05) (Fig. 7d). Such an
FIG. 6. SLP-2 binds cardiolipin. (a) Coprecipitation of hrSLP-2
with cardiolipin (CL) vesicles but not with other phospholipid vesicles
as shown by Western blotting of pellet (P) and supernatant (S) frac-
tions. PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI,
phosphatidylinositol; PS, phosphatidylserine; PG, phosphatidylglyc-
erol; Total protein, hrSLP-2 aliquot as used for coprecipitation. (b)
Titration of hrSLP-2 coprecipitation with CL in mixed CL-PC-PE
vesicles at the indicated ratios. An additional group containing twice
the amount of hrSLP-2 (CL  2 SLP-2) was added.
FIG. 5. SLP-2 interacts with prohibitins. (a) Immunoprecipitates with an antiserum against human SLP-2 or with a preimmune serum
from SLP-2-expressing Jurkat T cells were serially blotted for prohibitin 1 (PHB-1), PHB-2, or SLP-2. WCL, whole-cell lysate; IP,
immunoprecipitating antiserum; Beads, no-cell-lysate control; Pre-Imm, control immunoprecipitation with preimmune serum. (b) Immu-
noprecipitates and whole-cell lysates from SLP-2-GFP cells induced to express increasing amounts of SLP-2 by increasing concentrations of
doxycycline were collected and blotted as for Fig. 4b. (c) Mitochondria were isolated from SLP-2hi and SLP-2lo cells and were treated with
Na2CO3 in order to examine the membrane association of prohibitins in the presence of elevated SLP-2 expression. The fractions were
serially blotted for PHB-1 and SLP-2.
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increase in ATP levels in SLP-2hi T cells correlated with in-
creased resistance to depletion of mitochondrial ATP with
oligomycin, as evidenced by increased T-cell responses, indi-
cated by increased IL-2 production. In these experiments,
oligomycin-treated SLP-2lo T cells and SLP-2hi T cells were
stimulated with antigen-presenting cells and the superantigen
staphylococcal enterotoxin E (SEE), and the production of
interleukin-2 (IL-2) was determined after 24 h of stimulation.
FIG. 7. Induction of SLP-2 expression is associated with higher mitochondrial activity. (a) Citrate synthase (CS) activity was measured in
SLP-2lo and SLP-2hi Jurkat T cells. Data are means and standard deviations for triplicate samples; **, P 0.01. Data are expressed as nmol/min/mg
mitochondrial protein. (b) NADH dehydrogenase was measured in SLP-2lo and SLP-2hi Jurkat T cells, plotted as in panel a. *, P  0.05. (c)
Succinate dehydrogenase (SDH) was measured in SLP-2lo and SLP-2hi Jurkat T cells, plotted as in panel a. *, P  0.05. Data are expressed as
nmol/min/mg mitochondrial protein. (d) Mitochondrial and total cellular ATP levels were measured in SLP-2lo and SLP-2hi Jurkat T cells. Means
and standard deviations for triplicate samples are plotted. *, P  0.05; **, P  0.01. (e and f) IL-2 levels in culture supernatants of SLP-2
lo (e)
and SLP-2hi (f) Jurkat T cells pretreated or not with oligomycin (4 M) and stimulated with antigen-presenting cells and SEE for 24 h. Means and
standard deviations for triplicate samples are plotted. Asterisks indicate significant differences (*, P  0.05; ***, P  0.001) as determined by
analysis of variance (ANOVA) with a Bonferroni posttest. (g) Oxygen consumption was measured in SLP-2lo and SLP-2hi T cells in media
containing high (11 mM) or low (0.4 mM) glucose levels. Means and standard deviations for triplicate samples are plotted. Asterisks indicate
significant differences (*, P  0.05; **, P  0.01) as determined by ANOVA with a Bonferroni posttest. (h) Mitochondria were isolated from
SLP-2lo and SLP-2hi cells, separated by SDS-PAGE, and serially blotted for subunits of each complex of the respiratory chain as well as SLP-2.
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Oligomycin treatment significantly reduced the IL-2 response
of SLP-2lo T cells to SEE (P  0.001) (Fig. 7e) but did not
affect the response of SLP-2hi T cells (Fig. 7f). Consistent with
our previous findings, SLP-2hi T cells had a higher IL-2 re-
sponse than SLP-2lo T cells (28).
Given that the generation of ATP by OXPHOS is linked to
the respiratory chain in the mitochondrial inner membrane, we
examined the effect of modulating SLP-2 expression on oxygen
consumption by T cells. We found that SLP-2hi T cells had
slightly but significantly higher oxygen consumption than SLP-
2lo T cells (P 0.05). In a low-glucose medium, SLP-2hi T cells
had much higher oxygen consumption than SLP-2lo T cells
(P  0.01) (Fig. 7g). This is expected, since cells rely more
heavily on OXPHOS under low-glucose conditions. Therefore,
we concluded that upregulation of SLP-2 expression is associ-
ated with increased oxygen consumption and OXPHOS, lead-
ing to increased ATP stores in the cell.
Cardiolipin plays an essential role in the mitochondrial
protein import machinery (26), and as such, the increase in
cardiolipin levels seen in response to SLP-2 upregulation
could lead to an increased rate of protein transport into the
mitochondria. If so, the increased enzymatic rates we detected
in SLP-2hi cells could be due to elevated protein levels in the
mitochondria. To test this, mitochondria were isolated from
SLP-2lo and SLP-2hi cells, and lysates from these mitochondria
were blotted for representative subunits of each complex of the
respiratory chain. SLP-2lo and SLP-2hi cells had similar protein
levels for each complex of the respiratory chain (Fig. 7h),
indicating that the increase in enzymatic activity seen in the
SLP-2-overexpressing cells was not due to increased levels or
increased translocation of electron transport complexes into
mitochondria.
Upregulation of SLP-2 expression increases T cell responses
and resistance to apoptosis. In light of the significantly en-
hanced mitochondrial biogenesis and function associated with
SLP-2 upregulation, we examined the physiological effects of
these changes by looking at the functional response of primary
human T cells in which SLP-2 expression was upregulated. As
shown in Fig. 8a, peripheral blood T cells from normal volun-
teers transiently nucleofected with doxycycline-inducible SLP-
2-GFP cDNA and expressing high levels of SLP-2 produced
significantly higher levels of IL-2 (P  0.05) upon stimulation
with SEE and antigen-presenting cells. In addition, these cells
showed increased resistance to apoptosis through the intrinsic
FIG. 8. SLP-2 upregulation increases T cell responses and protects against apoptosis. (a) Human peripheral blood T cells nucleofected with
doxycycline-inducible SLP-2-GFP and expressing high levels of SLP-2 (SLP-2hi) upon doxycycline induction produce significantly more IL-2 in
response to stimulation with antigen-presenting cells and SEE than control (noninduced) SLP-2-GFP-transfected T cells. **, P 0.01; *, P 0.05.
(b) SLP-2hi primary T cells are less susceptible to actinomycin D-induced apoptosis. Human PBMCs were transiently transfected with doxycycline-
inducible SLP-2-GFP and were cultured with (SLP-2hi) (shaded histogram) or without (SLP-2lo) (open histogram) doxycycline and with actino-
mycin D (5 g/ml) for 3 h at 37°C. Cell death was measured by MitoTracker Red staining, which was analyzed by flow cytometry. (c) Upregulation
of SLP-2 expression in doxycycline-inducible SLP-2-GFP-transfected Jurkat T cells results in increased resistance to actinomycin D-induced
apoptosis. SLP-2hi (shaded histogram) and SLP-2lo (open histogram) T cells were treated with 5 g/ml actinomycin D for 3 h at 37°C. (d) SLP-2hi
(open bars) and SLP-2lo (filled bars) T cells were treated with actinomycin D (Act D) and were stained for annexin V, an alternative marker of
apoptosis. ***, P  0.001. (e) One representative flow cytometry plot of annexin V staining of SLP-2
hi (shaded histogram) and SLP-2lo (open
histogram) cells after induction of apoptosis with actinomycin D. The result for the unstained control is shown by a dotted line. The data are
representative of three independent experiments.
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pathway (Fig. 8b). Such resistance to apoptosis was also ob-
served in response to actinomycin D in Jurkat SLP-2hi T cells
(Fig. 8c). As an additional marker of apoptosis, actinomycin
D-induced cell death was also measured by an increase in
annexin V labeling. In agreement with the loss of transmem-
brane potential as measured by MitoTracker Red, SLP-2hi
cells also showed lower annexin V staining, which is indicative
of protection against the induction of the intrinsic apoptosis
pathway (Fig. 8d and e). Thus, consistent with the increased
mitochondrial biogenesis and function, upregulation of SLP-2
expression enhances cell function.
DISCUSSION
The function of stomatins and other proteins sharing the
stomatin/prohibitin/flotillin/HflK (SPFH) domain remain enig-
matic. It has been proposed that through this domain, stom-
atins, PHBs, and flotillins interact with different cell mem-
branes and facilitate signaling. We report here that SLP-2, a
mitochondrial member of the stomatin family, binds cardio-
lipin and may help to recruit PHBs to cardiolipin-enriched
microdomains. Furthermore, upregulation of SLP-2 expression
is associated with increased mitochondrial biogenesis and func-
tion, ultimately resulting in enhanced effector cell function.
Our data show that SLP-2 binds cardiolipin-enriched mi-
crodomains in a way that titrates with the content of cardiolipin
in phospholipid membranes. The mitochondrial membrane is
composed of 40% phosphatidylcholine, 30% phosphatidyl-
ethanolamine, and 10 to 15% phosphatidylinositol and cardio-
lipin (36). But the cardiolipin content in the mitochondrial
membrane is not homogeneously distributed. Our data suggest
that SLP-2 can bind to clusters of cardiolipin, i.e., microdo-
mains with a much higher localized cardiolipin concentration.
This selective binding of SLP-2 to cardiolipin is reminiscent
of the observation that two other members of the stomatin/
PHB/flotillin/HflK superfamily (MEC-2 and podocin) bind
cholesterol (24) and leads us to propose that SPFH domain-
containing proteins bind to selective phospholipid-enriched
membrane microdomains and may act as markers that recruit
other proteins to the lipid microdomains. How these proteins
bind lipids is still unknown. The binding of SLP-2 to cardiolipin
in the mitochondrial inner membrane is likely independent of
transmembrane insertion, since SLP-2 lacks a putative trans-
membrane domain (43).
Upregulation of SLP-2 expression increases cardiolipin syn-
thesis and mitochondrial biogenesis. Recent evidence indicates
that these two processes are tightly coordinated (17), likely
through the PHB functional interactome, which includes genes
involved in phospholipid synthesis, such as Ups1, whose dele-
tion, in yeast, translates into a marked decrease in cardiolipin
content (35). Although we have not shown a direct interaction
among PHBs, SLP-2, and cardiolipin, our data suggest that
SLP-2 may bring PHBs to cardiolipin and may contribute to
the organization of cardiolipin-enriched microdomains in the
mitochondrial inner membrane (3). Data from our laboratory
using T cell-specific SLP-2 knockout mice seem to corroborate
this model (D. A. Christie et al., unpublished data). This pos-
sible mechanism accommodates the upregulation of both
SLP-2 and PHBs during T cell activation (38) and the detec-
tion of both proteins in detergent-insoluble microdomains of
cell membranes (i.e., cardiolipin-enriched microdomains in the
mitochondrial inner membrane and cholesterol-enriched mi-
crodomains in the plasma membrane) (13, 27, 28, 33). In this
context, an increase in SLP-2 levels as a result of cell activation
would increase the interaction of PHBs with cardiolipin in the
mitochondrial inner membrane and activate the PHB func-
tional interactome, leading to de novo cardiolipin synthesis.
Using human T cell activation as a model, we have shown
that upregulation of SLP-2 expression is a molecular step be-
tween mitochondrial biogenesis and cell activation and func-
tion. SLP-2 does not seem to be critical under resting condi-
tions, as suggested by the absence or very low level of SLP-2
expression in resting naïve T cells. However, during T cell
activation, SLP-2 expression is dramatically upregulated, and
this increases T cell function, leading to increased IL-2 pro-
duction and increased resistance to apoptosis through the
intrinsic pathway. PHBs are also upregulated during T cell
activation (38), whereas PHB-2 deletion decreases the abil-
ity of cells to proliferate and increases their sensitivity to
apoptosis through the intrinsic pathway (32). These obser-
vations corroborate the model proposed here by which SLP-
2–PHB complexes would act in concert to regulate mito-
chondrial biogenesis and function during T cell activation.
Of interest, modulation of PHB-2 levels also alters OPA-1
levels (e.g., cells lacking PHB-2 have impaired processing of
OPA-1 [3]), and in our experiments, T cells overexpressing
SLP-2 have increased OPA-1 levels.
The increased mitochondrial function observed in SLP-2-
overexpressing cells is in line with the observation that SLP-2
controls the stability and the assembly of electron transport
complexes (1, 23). This is further corroborated by emerging
data from our laboratory using T cell-specific SLP-2-deficient
mice, showing that a lack of SLP-2 is associated with decreased
recruitment of PHB-1 to cardiolipin-enriched mitochondrial
membranes, as well as a loss of complex I subunits (D. A.
Christie et al., unpublished data). Optimal assembly of these
complexes may require the formation of specialized membrane
microdomains, and this would correlate with increased respi-
ratory chain function. Of interest, SLP-2 is required for mito-
chondrial hyperfusion (42), a phenomenon linked with in-
creased metabolic demands and cellular stress. Levels of both
OPA-1 and mitofusin-2, proteins required for this process,
were increased upon SLP-2 upregulation, but cytochrome c
levels were not. It is possible that SLP-2 expression specifically
increases the expression of proteins involved in mitochondrial
fusion, or prevents these proteins from degradation, without
altering the expression of other mitochondrial proteins.
Taken together, the evidence presented here leads us to
propose that the binding of SLP-2 to cardiolipin recruits PHBs,
helping to form cardiolipin-enriched membrane microdomains
in which the respiratory chain components are optimally as-
sembled. The formation of these microdomains is likely the
result of the self-oligomerizing properties of SLP-2 (43). The
increase in respiratory chain function may then induce further
cardiolipin synthesis through its effect on the pH gradient
across the mitochondrial inner membrane (18), enhancing mi-
tochondrial biogenesis. The result of this proposed mechanism
is the provision of the enhanced mitochondrial function re-
quired for an optimal T cell response.
How the increased mitochondrial membrane formation
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increases nuclear transcription and mitochondrial DNA rep-
lication, both required to increase mitochondrial numbers,
remains to be determined. A retrograde nuclear signaling
pathway in yeast is starting to emerge, but little is known about
this pathway in mammalian cells. Specific signals may involve
mitochondrial stress, since it has been shown that mitochon-
drial dysfunction increases nuclear transcription (40). In this
context, SLP-2 may play a role by regulating mitochondrial
membrane biogenesis and its subsequent effect of calcium-
dependent signaling, which has been linked to the activation of
retrograde signaling (6).
In summary, we have shown that increased levels of SLP-2,
seen, for example, during lymphocyte activation, stimulate mi-
tochondrial biogenesis and function, providing for the ener-
getic requirements of activation. Such a function involves the
binding of SLP-2 and its interacting partners (PHBs) to cardio-
lipin to form membrane microdomains in which respiratory
complexes are optimally assembled. The ultimate result of this
function is the net enhancement of effector cell functions.
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